Prosecution Insights
Last updated: May 29, 2026

Examiner: TAYLOR, MARISSA ENVENESIA

Tech Center 3700 • Art Units: 3783

This examiner grants 74% of resolved cases

Performance Statistics

73.7%
Allow Rate
+3.7% vs TC avg
44
Total Applications
+41.7%
Interview Lift
1340
Avg Prosecution Days
Based on 19 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
3.4%
§102 Novelty
81.4%
§103 Obviousness
15.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17762266 APPARATUS WITH INSERTION TUBE HAVING VARYING DUROMETER VALUE Final Rejection KONINKLIJKE PHILIPS N.V.
17933150 LOCK ADAPTER, SYRINGE ASSEMBLY, AND PREFILLED SYRINGE Final Rejection TERUMO KABUSHIKI KAISHA
18112018 SEAMLESS EXPANDABLE INTRODUCER SHEATH Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18086090 MEDICAL DEVICE ADAPTED FOR MULTIPLE IMPLANT RECAPTURES Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
17952746 INTRAVENOUS SET WITH PUMP INTERFACE FOR RAPID INFUSION VIA REUSABLE DRIVER Non-Final OA CareFusion 303, Inc.
17888197 DUAL CHAMBER BLOOD HAND PUMP Final Rejection CAREFUSION 303, INC.
18157922 MEDICAL DEVICE WITH A FOUR- LEAD THREAD, LUER CONNECTOR Non-Final OA Becton, Dickinson and Company
17768454 PERIPHERALLY INSERTED LEFT VENTRICULAR VENT AND ANTICOAGULATION CATHETER SYSTEM Non-Final OA Duke University
17961849 CATHETER WITH MULTIPLE BRAID LAYERS Final Rejection Surmodics MD, LLC
18371140 SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICES Non-Final OA INTERRAD Medical, Inc.
18263921 INJECTION DEVICE Non-Final OA Owen Mumford Limited
18004047 SEMI-AUTOMATICALLY CONTROLLABLE SYRINGES Final Rejection SHIVANI SCIENTIFIC INDUSTRIES PVT LTD
17795344 TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY Non-Final OA ISOLA THERAPEUTICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month